These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38747814)

  • 1. Identifying malignant mesothelioma by a pathological survey using the São Paulo state hospital cancer registry, Brazil.
    Bernardi FDC; Algranti E; Dolhnikoff M; Pinto CAL; Oliveira IM; Coletta ENAM; Silva ECAD; Nunes AJF; Veneziano DB; Luizaga CTM; Lorenzi RL; Silva DRME; Mauad T
    J Bras Pneumol; 2024; 50(2):e20230343. PubMed ID: 38747814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].
    Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F
    Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Accuracy of Mesothelioma Diagnosis in China.
    Guo Z; Carbone M; Zhang X; Su D; Sun W; Lou J; Gao Z; Shao D; Chen J; Zhang G; Hu J; Chen K; Wang F; Pass HI; Yu H; Napolitano A; Yang H; Mao W
    J Thorac Oncol; 2017 Apr; 12(4):714-723. PubMed ID: 28007630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement.
    Saad RS; Lindner JL; Lin X; Liu YL; Silverman JF
    Diagn Cytopathol; 2006 Dec; 34(12):801-6. PubMed ID: 17115439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of immunohistochemical evaluation in the diagnosis of malignant mesothelioma of the pleura.
    Panjković M; Lovrenski A; Eri Z; Usaj SK; Tegeltija D; Krcedinac J
    Vojnosanit Pregl; 2013 Nov; 70(11):1010-4. PubMed ID: 24397195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
    Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
    Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endobronchial ultrasound-guided fine needle aspiration in the diagnosis of pleural mesothelioma.
    Ghigna MR; Crutu A; Florea V; Soummer-Feulliet S; Baldeyrou P
    Cytopathology; 2016 Aug; 27(4):284-8. PubMed ID: 26315262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.
    Ascoli V; Minelli G; Cozzi I; Romeo E; Carnovale Scalzo C; Ancona L; Forastiere F
    Pathol Res Pract; 2016 Oct; 212(10):886-892. PubMed ID: 27485167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
    Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
    Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
    Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
    Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of second primary cancers after malignant mesothelioma and vice versa.
    Chen T; Kharazmi E; Lou J; Zhang X; Sundquist K; Hemminki K
    Cancer Lett; 2016 Aug; 379(1):94-9. PubMed ID: 27260871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.
    Sandeck HP; Røe OD; Kjærheim K; Willén H; Larsson E
    Diagn Pathol; 2010 Jul; 5():47. PubMed ID: 20602796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in malignant pleural mesothelioma.
    Davidson B
    Hum Pathol; 2015 Jun; 46(6):789-804. PubMed ID: 25824607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
    Barbieri PG
    Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
    [No Abstract]   [Full Text] [Related]  

  • 15. High frequency and severity of pleural changes in former workers exposed to anthophyllite associated with other contaminating amphibole asbestos in Brazil.
    Macedo RF; Cerqueira EMFP; Algranti E; Silva D; De Capitani EM
    Am J Ind Med; 2019 Jun; 62(6):503-510. PubMed ID: 31046142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A proposal for the creation of a system to monitor cases of malignant mesothelioma in Curitiba, Paraná, Brazil].
    Kalinke LP; Kalinke MA; Sarquis LMM; Marcondes L; Halfeld T; Mensi C; Consonni D
    Cad Saude Publica; 2018 Sep; 34(9):e00171917. PubMed ID: 30281709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.
    Muruganandan S; Alfonso H; Franklin P; Shilkin K; Segal A; Olsen N; Reid A; de Klerk N; Musk AB; Brims F
    Br J Cancer; 2017 Mar; 116(6):703-708. PubMed ID: 28196068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
    McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
    Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant Cytokeratin 20 Reactivity in Epithelioid Malignant Mesothelioma: A Case Report.
    Manur R; Lamzabi I
    Appl Immunohistochem Mol Morphol; 2019; 27(10):e93-e96. PubMed ID: 28248731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value.
    Shaker N; Wu D; Abid AM
    Diagn Cytopathol; 2022 Nov; 50(11):532-537. PubMed ID: 36069384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.